Last reviewed · How we verify

NCT05306535

Effect of Occlusal Reduction on Relief of Pain and Sensitivity to Percussion in Patients With Irreversible Pulpitis

Completed NA Last updated 24 August 2022
What this trial tests

NA trial testing Occlusal reduction in Post Operative Pain in 56 participants. Completed in 30 June 2022.

Timeline
1 April 2022
Primary endpoint
1 April 2022
30 June 2022

Quick facts

Lead sponsorAltamash Institute of Dental Medicine
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment56
Start date1 April 2022
Primary completion1 April 2022
Estimated completion30 June 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Altamash Institute of Dental Medicine

Who can join

Adults 18 to 50, any sex, with Post Operative Pain or Post-Op Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One of the most important aspects of endodontic practice is to abate pain during and post root canal treatment. An endodontist by all means should provide a painless endodontic treatment to their patients. This study is carried out to determine the effect of occlusal reduction on relief of pain and percussion in patients with irreversible pulpitis and symptomatic apical periodontitis treated in a single visit root canal treatment. Pain will be assessed preoperatively and then post operatively after completion of the root canal at 6 hours, 12 hours, 24 hours, 48 hours and 72 hours following obturation of root canal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Occlusal reduction

Trials testing the same drug.

Other recruiting trials for Post Operative Pain

Currently open trials in the same condition.

Other Altamash Institute of Dental Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing